Mouse Anti-CSTF2 Recombinant Antibody (0248) (V2LY-0125-LY190)

Masoumzadeh, E., Grozdanov, P. N., Jetly, A., MacDonald, C. C., & Latham, M. P. (2022). Electrostatic interactions between CSTF2 and pre-mRNA drive cleavage and polyadenylation. Biophysical Journal.

Mamoor, S. (2021). Differential expression of cleavage stimulation factor subunit 2 in cancers of the breast.

Grozdanov, P. N., Masoumzadeh, E., Kalscheuer, V. M., Bienvenu, T., Billuart, P., Delrue, M. A., ... & MacDonald, C. C. (2020). A missense mutation in the CSTF2 gene that impairs the function of the RNA recognition motif and causes defects in 3′ end processing is associated with intellectual disability in humans. Nucleic acids research, 48(17), 9804-9821.

Chen, X., Zhang, J. X., Luo, J. H., Wu, S., Yuan, G. J., Ma, N. F., ... & Xie, D. (2018). CSTF2-induced shortening of the RAC1 3′ UTR promotes the pathogenesis of urothelial carcinoma of the bladder. Cancer research, 78(20), 5848-5862.

Popow, J., Wieshofer, C., Schlattl, A., Woehrle, S., Neumüller, R., Petronczki, M. P., ... & Pearson, M. (2018). Synthetic lethality between CSTF2 and CSTF2T in lung adenocarcinoma and melanoma cell lines.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols